Active ingredientRetigabineCat. No. P-R044-001CAS 150812-12-7Family · Pharmaceutical analytical standards
Retigabine
An antiepileptic also known as ezogabine, with an original mechanism: it opens KCNQ (Kv7) potassium channels in the brain, stabilising neurons. It was approved in the European Union in 2011 as an add-on treatment for partial epilepsies in adults. This family brings together the active ingredient, labelled standards, nitrosamines and other impurities.
Did you know?It is a chemical 'cousin' of flupirtine, a painkiller with a similar mechanism: the two molecules differ mainly in one ring, a benzene ring in retigabine and a pyridine ring in flupirtine.
Go to the active ingredient →Active ingredientRetigabineCat. No. P-R044-001CAS 150812-12-7
Isotopically labelledRetigabine (Ezogabine)-d5 DiHClCat. No. P-R044-005CAS 1432063-93-8
Isotopically labelledRetigabine Impurity 3 Dihydrochloride-d3Cat. No. P-R044-006
Isotopically labelledRetigabine Impurity 3 Dihydrochloride-d4Cat. No. P-R044-007
NitrosamineN-Nitroso RetigabineCat. No. P-R044-008
ImpurityN-Acetyl RetigabineCat. No. P-R044-009
Active ingredientRetigabine DiHClCat. No. P-R044-010CAS 150812-13-8
ImpurityRetigabine Impurity 1Cat. No. P-R044-011
ImpurityRetigabine Impurity 2Cat. No. P-R044-012
ImpurityRetigabine N-beta-D-glucoside 1Cat. No. P-R044-013
ImpurityRetigabine N-beta-D-glucoside 2Cat. No. P-R044-014
ImpurityRetigabine(Ezogabine) N-Acetyl diHClCat. No. P-R044-015No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.